Lifting the veil on amyloid drug design.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 23878728.
- Also identified by DOI 10.7554/eLife.01089 and PMC identifier 3713451.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
High resolution structures and computational methods have been used to identify compounds that prevent amyloid fibrils associated with Alzheimer's disease from dissociating into toxic species.
Medical subject headings
- Amyloid beta-Peptides